Oldfield Leslie E, Connor Ashton A, Gallinger Steven
PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Canada.
Trends Cancer. 2017 May;3(5):336-346. doi: 10.1016/j.trecan.2017.04.005. Epub 2017 May 10.
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest epithelial malignancies. Improvements in our understanding of PDAC carcinogenesis will hopefully improve its detection, management, and outcomes, as has been achieved with other malignancies. Here we review the literature on the natural history of PDAC, including its cell of origin, the initiating somatic mutational events, pathways deranged in the mature tumor, its biological heterogeneity, and the relationship of the primary tumor with metastases. We also suggest areas for further research and highlight translatable findings that are beginning to make clinical inroads.
胰腺导管腺癌(PDAC)是最致命的上皮性恶性肿瘤之一。正如在其他恶性肿瘤中所实现的那样,加深对PDAC致癌作用的理解有望改善其检测、管理及治疗结果。在此,我们综述了关于PDAC自然史的文献,包括其起源细胞、起始体细胞突变事件、成熟肿瘤中紊乱的信号通路、其生物学异质性以及原发性肿瘤与转移灶的关系。我们还提出了进一步研究的领域,并强调了已开始在临床上取得进展的可转化研究结果。